Greener T, Boland K, Milgrom R, Ben-Bassat O, et al. Higher adalimumab maintenance regimen is more effective than standard dose in anti-TNF experienced Crohn's disease patients. Eur J Gastroenterol Hepatol 2021;33:1274-1279.
PMID: 34402466